Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Cirrhosis

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 192 articles:
HTML format
Text format



Single Articles


    January 2017
  1. YANG SC, Hsu CN, Liang CM, Tai WC, et al
    Risk of Rebleeding and Mortality in Cirrhotic Patients with Peptic Ulcer Bleeding: A 12-Year Nationwide Cohort Study.
    PLoS One. 2017;12:e0168918.
    PubMed     Text format     Abstract available


  2. DEGRE D, Serste T, Lasser L, Delwaide J, et al
    Sofosbuvir in Combination with Simeprevir +/- Ribavirin in Genotype 4 Hepatitis C Patients with Advanced Fibrosis or Cirrhosis: A Real-World Experience from Belgium.
    PLoS One. 2017;12:e0170933.
    PubMed     Text format     Abstract available


  3. GIMENEZ-GARZO C, Garces JJ, Urios A, Mangas-Losada A, et al
    The PHES battery does not detect all cirrhotic patients with early neurological deficits, which are different in different patients.
    PLoS One. 2017;12:e0171211.
    PubMed     Text format     Abstract available


  4. TRAYKOVA D, Schneider B, Chojkier M, Buck M, et al
    Blood Microbiome Quantity and the Hyperdynamic Circulation in Decompensated Cirrhotic Patients.
    PLoS One. 2017;12:e0169310.
    PubMed     Text format     Abstract available


  5. HOLLENBACH M, Thonig A, Pohl S, Ripoll C, et al
    Expression of glyoxalase-I is reduced in cirrhotic livers: A possible mechanism in the development of cirrhosis.
    PLoS One. 2017;12:e0171260.
    PubMed     Text format     Abstract available


  6. BECKER S, Kinny-Koster B, Bartels M, Scholz M, et al
    Low sphingosine-1-phosphate plasma levels are predictive for increased mortality in patients with liver cirrhosis.
    PLoS One. 2017;12:e0174424.
    PubMed     Text format     Abstract available


    January 2016
  7. THOMSEN KL, Macnaughtan J, Tritto G, Mookerjee RP, et al
    Clinical and Pathophysiological Characteristics of Cirrhotic Patients with Grade 1 and Minimal Hepatic Encephalopathy.
    PLoS One. 2016;11:e0146076.
    PubMed     Text format     Abstract available


  8. LI TH, Huang CC, Yang YY, Lee KC, et al
    Thalidomide Improves the Intestinal Mucosal Injury and Suppresses Mesenteric Angiogenesis and Vasodilatation by Down-Regulating Inflammasomes-Related Cascades in Cirrhotic Rats.
    PLoS One. 2016;11:e0147212.
    PubMed     Text format     Abstract available


  9. JIAO J, Watt GP, Lee M, Rahbar MH, et al
    Cirrhosis and Advanced Fibrosis in Hispanics in Texas: The Dominant Contribution of Central Obesity.
    PLoS One. 2016;11:e0150978.
    PubMed     Text format     Abstract available


  10. CHEN QF, Chen HJ, Liu J, Sun T, et al
    Machine Learning Classification of Cirrhotic Patients with and without Minimal Hepatic Encephalopathy Based on Regional Homogeneity of Intrinsic Brain Activity.
    PLoS One. 2016;11:e0151263.
    PubMed     Text format     Abstract available


  11. ROMAN E, Garcia-Galceran C, Torrades T, Herrera S, et al
    Effects of an Exercise Programme on Functional Capacity, Body Composition and Risk of Falls in Patients with Cirrhosis: A Randomized Clinical Trial.
    PLoS One. 2016;11:e0151652.
    PubMed     Text format     Abstract available


  12. ESTRELA HF, Damasio ES, Fonseca EK, Bergamaschi CT, et al
    Differential Sympathetic Vasomotor Activation Induced by Liver Cirrhosis in Rats.
    PLoS One. 2016;11:e0152512.
    PubMed     Text format     Abstract available


  13. ARAUJO OC, Rosa AS, Fernandes A, Niel C, et al
    RASSF1A and DOK1 Promoter Methylation Levels in Hepatocellular Carcinoma, Cirrhotic and Non-Cirrhotic Liver, and Correlation with Liver Cancer in Brazilian Patients.
    PLoS One. 2016;11:e0153796.
    PubMed     Text format     Abstract available


  14. WANG D, Chen TW, Zhang XM, Li J, et al
    Liver Lobe Based Multi-Echo Gradient Recalled Echo T2*-Weighted Imaging in Chronic Hepatitis B-Related Cirrhosis: Association with the Presence and Child-Pugh Class of Cirrhosis.
    PLoS One. 2016;11:e0154545.
    PubMed     Text format     Abstract available


  15. TISCHENDORF M, Miesbach W, Chattah U, Chattah Z, et al
    Differential Kinetics of Coagulation Factors and Natural Anticoagulants in Patients with Liver Cirrhosis: Potential Clinical Implications.
    PLoS One. 2016;11:e0155337.
    PubMed     Text format     Abstract available


  16. VESPASIANI-GENTILUCCI U, Gallo P, Piemonte F, Riva E, et al
    Lysosomal Acid Lipase Activity Is Reduced Both in Cryptogenic Cirrhosis and in Cirrhosis of Known Etiology.
    PLoS One. 2016;11:e0156113.
    PubMed     Text format     Abstract available


  17. D'AMBROSIO R, Degasperi E, Aghemo A, Fraquelli M, et al
    Serological Tests Do Not Predict Residual Fibrosis in Hepatitis C Cirrhotics with a Sustained Virological Response to Interferon.
    PLoS One. 2016;11:e0155967.
    PubMed     Text format     Abstract available


  18. LAHMER T, Brandl A, Rasch S, Schmid RM, et al
    Fungal Peritonitis: Underestimated Disease in Critically Ill Patients with Liver Cirrhosis and Spontaneous Peritonitis.
    PLoS One. 2016;11:e0158389.
    PubMed     Text format     Abstract available


  19. SANSOE G, Aragno M, Mastrocola R, Mengozzi G, et al
    Alpha-2A Adrenoceptor Agonist Guanfacine Restores Diuretic Efficiency in Experimental Cirrhotic Ascites: Comparison with Clonidine.
    PLoS One. 2016;11:e0158486.
    PubMed     Text format     Abstract available


  20. GRAUPERA I, Sola E, Fabrellas N, Moreira R, et al
    Urine Monocyte Chemoattractant Protein-1 Is an Independent Predictive Factor of Hospital Readmission and Survival in Cirrhosis.
    PLoS One. 2016;11:e0157371.
    PubMed     Text format     Abstract available


  21. ZHANG B, Liang L, Dong Y, Lian Z, et al
    Intravoxel Incoherent Motion MR Imaging for Staging of Hepatic Fibrosis.
    PLoS One. 2016;11:e0147789.
    PubMed     Text format     Abstract available


  22. LYTLE KA, Jump DB
    Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible?
    PLoS One. 2016;11:e0146942.
    PubMed     Text format     Abstract available


  23. PEREPELYUK M, Chin L, Cao X, van Oosten A, et al
    Normal and Fibrotic Rat Livers Demonstrate Shear Strain Softening and Compression Stiffening: A Model for Soft Tissue Mechanics.
    PLoS One. 2016;11:e0146588.
    PubMed     Text format     Abstract available


  24. KUMAR S, Wang J, Rani R, Gandhi CR, et al
    Hepatic Deficiency of Augmenter of Liver Regeneration Exacerbates Alcohol-Induced Liver Injury and Promotes Fibrosis in Mice.
    PLoS One. 2016;11:e0147864.
    PubMed     Text format     Abstract available


  25. PIRHONEN J, Arola J, Sadevirta S, Luukkonen P, et al
    Continuous Grading of Early Fibrosis in NAFLD Using Label-Free Imaging: A Proof-of-Concept Study.
    PLoS One. 2016;11:e0147804.
    PubMed     Text format     Abstract available


  26. FUJIMOTO Y, Urashima T, Shimura D, Ito R, et al
    Low Cardiac Output Leads Hepatic Fibrosis in Right Heart Failure Model Rats.
    PLoS One. 2016;11:e0148666.
    PubMed     Text format     Abstract available


  27. ALDAMIZ-ECHEVARRIA T, Berenguer J, Miralles P, Jimenez-Sousa MA, et al
    Soluble Adhesion Molecules in Patients Coinfected with HIV and HCV: A Predictor of Outcome.
    PLoS One. 2016;11:e0148537.
    PubMed     Text format     Abstract available


  28. TAPPER EB, Hunink MG, Afdhal NH, Lai M, et al
    Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score.
    PLoS One. 2016;11:e0147237.
    PubMed     Text format     Abstract available


  29. HAMETNER S, Ferlitsch A, Ferlitsch M, Etschmaier A, et al
    The VITRO Score (Von Willebrand Factor Antigen/Thrombocyte Ratio) as a New Marker for Clinically Significant Portal Hypertension in Comparison to Other Non-Invasive Parameters of Fibrosis Including ELF Test.
    PLoS One. 2016;11:e0149230.
    PubMed     Text format     Abstract available


  30. ARAUJO JUNIOR RF, Garcia VB, Leitao RF, Brito GA, et al
    Carvedilol Improves Inflammatory Response, Oxidative Stress and Fibrosis in the Alcohol-Induced Liver Injury in Rats by Regulating Kuppfer Cells and Hepatic Stellate Cells.
    PLoS One. 2016;11:e0148868.
    PubMed     Text format     Abstract available


  31. SOLOMON SS, Srikrishnan AK, McFall AM, Kumar MS, et al
    Burden of Liver Disease among Community-Based People Who Inject Drugs (PWID) in Chennai, India.
    PLoS One. 2016;11:e0147879.
    PubMed     Text format     Abstract available


  32. ALT Y, Grimm A, Schlegel L, Grambihler A, et al
    The Impact of Liver Cell Injury on Health-Related Quality of Life in Patients with Chronic Liver Disease.
    PLoS One. 2016;11:e0151200.
    PubMed     Text format     Abstract available


  33. JANG ES, Jeong SH, Kim JW, Choi YS, et al
    Diagnostic Performance of Alpha-Fetoprotein, Protein Induced by Vitamin K Absence, Osteopontin, Dickkopf-1 and Its Combinations for Hepatocellular Carcinoma.
    PLoS One. 2016;11:e0151069.
    PubMed     Text format     Abstract available


  34. SIEGMUND SV, Schlosser M, Schildberg FA, Seki E, et al
    Serum Amyloid A Induces Inflammation, Proliferation and Cell Death in Activated Hepatic Stellate Cells.
    PLoS One. 2016;11:e0150893.
    PubMed     Text format     Abstract available


  35. TANDON P, James MT, Abraldes JG, Karvellas CJ, et al
    Relevance of New Definitions to Incidence and Prognosis of Acute Kidney Injury in Hospitalized Patients with Cirrhosis: A Retrospective Population-Based Cohort Study.
    PLoS One. 2016;11:e0160394.
    PubMed     Text format     Abstract available


  36. CHOW LN, Schreiner P, Ng BY, Lo B, et al
    Impact of a CXCL12/CXCR4 Antagonist in Bleomycin (BLM) Induced Pulmonary Fibrosis and Carbon Tetrachloride (CCl4) Induced Hepatic Fibrosis in Mice.
    PLoS One. 2016;11:e0151765.
    PubMed     Text format     Abstract available


  37. BAIOCCHINI A, Montaldo C, Conigliaro A, Grimaldi A, et al
    Extracellular Matrix Molecular Remodeling in Human Liver Fibrosis Evolution.
    PLoS One. 2016;11:e0151736.
    PubMed     Text format     Abstract available


  38. TAWARA S, Tatsumi T, Iio S, Kobayashi I, et al
    Evaluation of Fucosylated Haptoglobin and Mac-2 Binding Protein as Serum Biomarkers to Estimate Liver Fibrosis in Patients with Chronic Hepatitis C.
    PLoS One. 2016;11:e0151828.
    PubMed     Text format     Abstract available


  39. ZHANG Z, Wang G, Kang K, Wu G, et al
    The Diagnostic Accuracy and Clinical Utility of Three Noninvasive Models for Predicting Liver Fibrosis in Patients with HBV Infection.
    PLoS One. 2016;11:e0152757.
    PubMed     Text format     Abstract available


  40. RACHAKONDA V, Borhani AA, Dunn MA, Andrzejewski M, et al
    Serum Leptin Is a Biomarker of Malnutrition in Decompensated Cirrhosis.
    PLoS One. 2016;11:e0159142.
    PubMed     Text format     Abstract available


  41. MONTALBANO M, Curcuru G, Shirafkan A, Vento R, et al
    Modeling of Hepatocytes Proliferation Isolated from Proximal and Distal Zones from Human Hepatocellular Carcinoma Lesion.
    PLoS One. 2016;11:e0153613.
    PubMed     Text format     Abstract available


  42. JI J, Wang H, Li Y, Zheng L, et al
    Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus alpha-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.
    PLoS One. 2016;11:e0153227.
    PubMed     Text format     Abstract available


  43. KLEIN S, Hinuber C, Hittatiya K, Schierwagen R, et al
    Novel Rat Model of Repetitive Portal Venous Embolization Mimicking Human Non-Cirrhotic Idiopathic Portal Hypertension.
    PLoS One. 2016;11:e0162144.
    PubMed     Text format     Abstract available


  44. SANSOE G, Aragno M, Mastrocola R, Mengozzi G, et al
    Role of Chymase in the Development of Liver Cirrhosis and Its Complications: Experimental and Human Data.
    PLoS One. 2016;11:e0162644.
    PubMed     Text format     Abstract available


  45. HUNG TH, Lay CJ, Tseng CW, Tsai CC, et al
    The Effect of Renal Function Impairment on the Mortality of Cirrhotic Patients: A Nationwide Population-Based 3-Year Follow-up Study.
    PLoS One. 2016;11:e0162987.
    PubMed     Text format     Abstract available


  46. SOBREVALS L, Enguita M, Quiroga J, Prieto J, et al
    Insulin-Like Growth Factor I (IGF-I) Expressed from an AAV1 Vector Leads to a Complete Reversion of Liver Cirrhosis in Rats.
    PLoS One. 2016;11:e0162955.
    PubMed     Text format     Abstract available


  47. YE Q, Qian BX, Yin WL, Wang FM, et al
    Association between the HFE C282Y, H63D Polymorphisms and the Risks of Non-Alcoholic Fatty Liver Disease, Liver Cirrhosis and Hepatocellular Carcinoma: An Updated Systematic Review and Meta-Analysis of 5,758 Cases and 14,741 Controls.
    PLoS One. 2016;11:e0163423.
    PubMed     Text format     Abstract available


  48. LIU TL, Barritt Iv AS, Weinberger M, Paul JE, et al
    Who Treats Patients with Diabetes and Compensated Cirrhosis.
    PLoS One. 2016;11:e0165574.
    PubMed     Text format     Abstract available


  49. FJELD K, Beer S, Johnstone M, Zimmer C, et al
    Length of Variable Numbers of Tandem Repeats in the Carboxyl Ester Lipase (CEL) Gene May Confer Susceptibility to Alcoholic Liver Cirrhosis but Not Alcoholic Chronic Pancreatitis.
    PLoS One. 2016;11:e0165567.
    PubMed     Text format     Abstract available


  50. FAN WC, Liu CW, Ou SM, Huang CC, et al
    TLR4/CD14 Variants-Related Serologic and Immunologic Dys-Regulations Predict Severe Sepsis in Febrile De-Compensated Cirrhotic Patients.
    PLoS One. 2016;11:e0166458.
    PubMed     Text format     Abstract available


  51. DELEURAN T, Vilstrup H, Overgaard S, Jepsen P, et al
    No Increased Risk for Primary Osteoarthritis in Liver Cirrhosis - A Danish Nationwide Cohort Study.
    PLoS One. 2016;11:e0167134.
    PubMed     Text format     Abstract available


  52. JEON I, Cho ES, Kim JH, Kim DJ, et al
    Feasibility of 10-Minute Delayed Hepatocyte Phase Imaging Using a 30 degrees Flip Angle in Gd-EOB-DTPA-Enhanced Liver MRI for the Detection of Hepatocellular Carcinoma in Patients with Chronic Hepatitis or Cirrhosis.
    PLoS One. 2016;11:e0167701.
    PubMed     Text format     Abstract available


  53. NUNEZ-TORRES R, Macias J, Mancebo M, Frias M, et al
    The PNPLA3 Genetic Variant rs738409 Influences the Progression to Cirrhosis in HIV/Hepatitis C Virus Coinfected Patients.
    PLoS One. 2016;11:e0168265.
    PubMed     Text format     Abstract available


  54. TUTTOLOMONDO A, Di Raimondo D, Bellia C, Clemente G, et al
    Immune-Inflammatory and Metabolic Effects of High Dose Furosemide plus Hypertonic Saline Solution (HSS) Treatment in Cirrhotic Subjects with Refractory Ascites.
    PLoS One. 2016;11:e0165443.
    PubMed     Text format     Abstract available


  55. SARRAZIN C, Manns M, Calleja JL, Garcia-Samaniego J, et al
    HCVerso3: An Open-Label, Phase IIb Study of Faldaprevir and Deleobuvir with Ribavirin in Hepatitis C Virus Genotype-1b-Infected Patients with Cirrhosis and Moderate Hepatic Impairment.
    PLoS One. 2016;11:e0168544.
    PubMed     Text format     Abstract available


  56. NOVO-VELEIRO I, Cieza-Borrella C, Pastor I, Chamorro AJ, et al
    A Single Nucleotide Polymorphism in the RASGRF2 Gene Is Associated with Alcoholic Liver Cirrhosis in Men.
    PLoS One. 2016;11:e0168685.
    PubMed     Text format     Abstract available


    January 2015
  57. FLASS T, Tong S, Frank DN, Wagner BD, et al
    Intestinal Lesions Are Associated with Altered Intestinal Microbiome and Are More Frequent in Children and Young Adults with Cystic Fibrosis and Cirrhosis.
    PLoS One. 2015;10:e0116967.
    PubMed     Text format     Abstract available


  58. TSAI HC, Lin YC, Ko CL, Lou HY, et al
    Propofol versus Midazolam for Upper Gastrointestinal Endoscopy in Cirrhotic Patients: A Meta-Analysis of Randomized Controlled Trials.
    PLoS One. 2015;10:e0117585.
    PubMed     Text format     Abstract available


  59. WU Z, Matsui O, Kitao A, Kozaka K, et al
    Hepatitis C Related Chronic Liver Cirrhosis: Feasibility of Texture Analysis of MR Images for Classification of Fibrosis Stage and Necroinflammatory Activity Grade.
    PLoS One. 2015;10:e0118297.
    PubMed     Text format     Abstract available


  60. FERRIN G, Rodriguez-Peralvarez M, Aguilar-Melero P, Ranchal I, et al
    Plasma Protein Biomarkers of Hepatocellular Carcinoma in HCV-Infected Alcoholic Patients with Cirrhosis.
    PLoS One. 2015;10:e0118527.
    PubMed     Text format     Abstract available


  61. LV XF, Liu K, Qiu YW, Cai PQ, et al
    Anomalous Gray Matter Structural Networks in Patients with Hepatitis B Virus-Related Cirrhosis without Overt Hepatic Encephalopathy.
    PLoS One. 2015;10:e0119339.
    PubMed     Text format     Abstract available


  62. MENG Y, Liang Y, Liu M
    The value of MRI in the diagnosis of primary biliary cirrhosis and assessment of liver fibrosis.
    PLoS One. 2015;10:e0120110.
    PubMed     Text format     Abstract available


  63. CHANG CH, Chen YC, Zhang W, Leung PS, et al
    Innate immunity drives the initiation of a murine model of primary biliary cirrhosis.
    PLoS One. 2015;10:e0121320.
    PubMed     Text format     Abstract available


  64. JEONG WK, Kim TY, Sohn JH, Kim Y, et al
    Severe portal hypertension in cirrhosis: evaluation of perfusion parameters with contrast-enhanced ultrasonography.
    PLoS One. 2015;10:e0121601.
    PubMed     Text format     Abstract available


  65. GOMEZ-ANSON B, Roman E, Fernandez de Bobadilla R, Pires-Encuentra P, et al
    Alterations in cerebral white matter and neuropsychology in patients with cirrhosis and falls.
    PLoS One. 2015;10:e0118930.
    PubMed     Text format     Abstract available


  66. MOELLER M, Thonig A, Pohl S, Ripoll C, et al
    Hepatic arterial vasodilation is independent of portal hypertension in early stages of cirrhosis.
    PLoS One. 2015;10:e0121229.
    PubMed     Text format     Abstract available


  67. PARK Y, Kim SU, Park SY, Kim BK, et al
    A novel model to predict esophageal varices in patients with compensated cirrhosis using acoustic radiation force impulse elastography.
    PLoS One. 2015;10:e0121009.
    PubMed     Text format     Abstract available


  68. CHEN H, Liu L, Qi X, He C, et al
    Imbalance of Pro- vs. Anti-Coagulation Factors in Chinese Patients with Budd-Chiari Syndrome and Non-Cirrhotic Portal Vein Thrombosis.
    PLoS One. 2015;10:e0119909.
    PubMed     Text format     Abstract available


  69. LIM N, Lidofsky SD
    Impact of Physician Specialty on Quality Care for Patients Hospitalized with Decompensated Cirrhosis.
    PLoS One. 2015;10:e0123490.
    PubMed     Text format     Abstract available


  70. SHEU MJ, Hsieh MJ, Chiang WL, Yang SF, et al
    Fibroblast growth factor receptor 4 polymorphism is associated with liver cirrhosis in hepatocarcinoma.
    PLoS One. 2015;10:e0122961.
    PubMed     Text format     Abstract available


  71. TUNG HC, Lee FY, Wang SS, Tsai MH, et al
    The Beneficial Effects of P2X7 Antagonism in Rats with Bile Duct Ligation-induced Cirrhosis.
    PLoS One. 2015;10:e0124654.
    PubMed     Text format     Abstract available


  72. LIN WC, Hsu TW, Chen CL, Lu CH, et al
    Resting State-fMRI with ReHo Analysis as a Non-Invasive Modality for the Prognosis of Cirrhotic Patients with Overt Hepatic Encephalopathy.
    PLoS One. 2015;10:e0126834.
    PubMed     Text format     Abstract available


  73. LIU X, Chi X, Gong Q, Gao L, et al
    Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
    PLoS One. 2015;10:e0127518.
    PubMed     Text format     Abstract available


  74. MERLI M, Lucidi C, Di Gregorio V, Falcone M, et al
    The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective survey.
    PLoS One. 2015;10:e0127448.
    PubMed     Text format     Abstract available


  75. ARIZA X, Sola E, Elia C, Barreto R, et al
    Analysis of a Urinary Biomarker Panel for Clinical Outcomes Assessment in Cirrhosis.
    PLoS One. 2015;10:e0128145.
    PubMed     Text format     Abstract available


  76. CHEN J, Zhang X, Xu Y, Li X, et al
    Hepatic Progenitor Cells Contribute to the Progression of 2-Acetylaminofluorene/Carbon Tetrachloride-Induced Cirrhosis via the Non-Canonical Wnt Pathway.
    PLoS One. 2015;10:e0130310.
    PubMed     Text format     Abstract available


  77. KIMURA T, Takahashi S, Takahashi I, Nishibuchi I, et al
    The Time Course of Dynamic Computed Tomographic Appearance of Radiation Injury to the Cirrhotic Liver Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma.
    PLoS One. 2015;10:e0125231.
    PubMed     Text format     Abstract available


  78. SEKIGUCHI T, Umemura T, Fujimori N, Shibata S, et al
    Serum Cell Death Biomarkers for Prediction of Liver Fibrosis and Poor Prognosis in Primary Biliary Cirrhosis.
    PLoS One. 2015;10:e0131658.
    PubMed     Text format     Abstract available


  79. MEIKLE PJ, Mundra PA, Wong G, Rahman K, et al
    Circulating Lipids Are Associated with Alcoholic Liver Cirrhosis and Represent Potential Biomarkers for Risk Assessment.
    PLoS One. 2015;10:e0130346.
    PubMed     Text format     Abstract available


  80. FINKELMEIER F, Kronenberger B, Zeuzem S, Piiper A, et al
    Low 25-Hydroxyvitamin D Levels Are Associated with Infections and Mortality in Patients with Cirrhosis.
    PLoS One. 2015;10:e0132119.
    PubMed     Text format     Abstract available


  81. LI R, Tang CL, Zhang Y, Ma KS, et al
    Diagnosis of Hepatic Angiomyolipoma by Combination of Baseline and Contrast-Enhanced Ultrasound-A Prospective Study in Non-Cirrhotic Patients.
    PLoS One. 2015;10:e0132290.
    PubMed     Text format     Abstract available


  82. CHO EJ, Kim MY, Lee JH, Lee IY, et al
    Diagnostic and Prognostic Values of Noninvasive Predictors of Portal Hypertension in Patients with Alcoholic Cirrhosis.
    PLoS One. 2015;10:e0133935.
    PubMed     Text format     Abstract available


  83. SANCHEZ-ANTOLIN G, Almohalla-Alvarez C, Bueno P, Almansa R, et al
    Evidence of Active Pro-Fibrotic Response in Blood of Patients with Cirrhosis.
    PLoS One. 2015;10:e0137128.
    PubMed     Text format     Abstract available


  84. GRAMMATIKOS G, Ferreiros N, Waidmann O, Bon D, et al
    Serum Sphingolipid Variations Associate with Hepatic Decompensation and Survival in Patients with Cirrhosis.
    PLoS One. 2015;10:e0138130.
    PubMed     Text format     Abstract available


  85. KERBERT AJ, Verbeke L, Chiang FW, Laleman W, et al
    Copeptin as an Indicator of Hemodynamic Derangement and Prognosis in Liver Cirrhosis.
    PLoS One. 2015;10:e0138264.
    PubMed     Text format     Abstract available


  86. LEPIDA A, Colombo M, Fernandez I, Abdurakhmanov D, et al
    Final Results of the Telaprevir Access Program: FibroScan Values Predict Safety and Efficacy in Hepatitis C Patients with Advanced Fibrosis or Cirrhosis.
    PLoS One. 2015;10:e0138503.
    PubMed     Text format     Abstract available


  87. KLEIN S, Herath CB, Schierwagen R, Grace J, et al
    Hemodynamic Effects of the Non-Peptidic Angiotensin-(1-7) Agonist AVE0991 in Liver Cirrhosis.
    PLoS One. 2015;10:e0138732.
    PubMed     Text format     Abstract available


  88. FORNARI F, Ferracin M, Trere D, Milazzo M, et al
    Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, Identify Cirrhotic Patients with HCC.
    PLoS One. 2015;10:e0141448.
    PubMed     Text format     Abstract available


  89. LIU F, Wang X, Wu G, Chen L, et al
    Coffee Consumption Decreases Risks for Hepatic Fibrosis and Cirrhosis: A Meta-Analysis.
    PLoS One. 2015;10:e0142457.
    PubMed     Text format     Abstract available


  90. LI RK, Palmer SL, Zeng MS, Qiang JW, et al
    Detection of Endogenous Iron Reduction during Hepatocarcinogenesis at Susceptibility-Weighted MR Imaging: Value for Characterization of Hepatocellular Carcinoma and Dysplastic Nodule in Cirrhotic Liver.
    PLoS One. 2015;10:e0142882.
    PubMed     Text format     Abstract available


  91. ABOUT F, Oudot-Mellakh T, Niay J, Rabiega P, et al
    Impact of IL28B, APOH and ITPA Polymorphisms on Efficacy and Safety of TVR- or BOC-Based Triple Therapy in Treatment-Experienced HCV-1 Patients with Compensated Cirrhosis from the ANRS CO20-CUPIC Study.
    PLoS One. 2015;10:e0145105.
    PubMed     Text format     Abstract available


  92. MATSUE Y, Tsutsumi M, Hayashi N, Saito T, et al
    Serum osteopontin predicts degree of hepatic fibrosis and serves as a biomarker in patients with hepatitis C virus infection.
    PLoS One. 2015;10:e0118744.
    PubMed     Text format     Abstract available


  93. LIU Y, Huang L, Lu Y, Xi XE, et al
    Relationships between the Osteocalcin Gene Polymorphisms, Serum Osteocalcin Levels, and Hepatitis B Virus-Related Hepatocellular Carcinoma in a Chinese Population.
    PLoS One. 2015;10:e0116479.
    PubMed     Text format     Abstract available


  94. HOFFMANN CJ, Hoffmann JD, Kensler C, van der Watt M, et al
    Tuberculosis and Hepatic Steatosis Are Prevalent Liver Pathology Findings among HIV-Infected Patients in South Africa.
    PLoS One. 2015;10:e0117813.
    PubMed     Text format     Abstract available


  95. LIN YY, Shiau S, Fang CT
    Risk Factors for Invasive Cryptococcus neoformans Diseases: A Case-Control Study.
    PLoS One. 2015;10:e0119090.
    PubMed     Text format     Abstract available


  96. JIA Y, Zeng Z, Li Y, Li Z, et al
    Impaired function of CD4+ T follicular helper (Tfh) cells associated with hepatocellular carcinoma progression.
    PLoS One. 2015;10:e0117458.
    PubMed     Text format     Abstract available


  97. JANSEN C, Reiberger T, Huang J, Eischeid H, et al
    Circulating MiRNA-122 Levels Are Associated with Hepatic Necroinflammation and Portal Hypertension in HIV/HCV Coinfection.
    PLoS One. 2015;10:e0116768.
    PubMed     Text format     Abstract available


  98. DECARIS ML, Emson CL, Li K, Gatmaitan M, et al
    Turnover rates of hepatic collagen and circulating collagen-associated proteins in humans with chronic liver disease.
    PLoS One. 2015;10:e0123311.
    PubMed     Text format     Abstract available


  99. TAN Y, Ye Y, Zhou X, Chen L, et al
    Age as a Predictor of Significant Fibrosis Features in HBeAg-Negative Chronic Hepatitis B Virus Infection with Persistently Normal Alanine Aminotransferase.
    PLoS One. 2015;10:e0123452.
    PubMed     Text format     Abstract available


  100. HOCHST B, Mikulec J, Baccega T, Metzger C, et al
    Differential induction of Ly6G and Ly6C positive myeloid derived suppressor cells in chronic kidney and liver inflammation and fibrosis.
    PLoS One. 2015;10:e0119662.
    PubMed     Text format     Abstract available


  101. PARENTE DB, Paiva FF, Oliveira Neto JA, Machado-Silva L, et al
    Intravoxel Incoherent Motion Diffusion Weighted MR Imaging at 3.0 T: Assessment of Steatohepatitis and Fibrosis Compared with Liver Biopsy in Type 2 Diabetic Patients.
    PLoS One. 2015;10:e0125653.
    PubMed     Text format     Abstract available


  102. KNABEL MK, Ramachandran K, Karhadkar S, Hwang HW, et al
    Systemic Delivery of scAAV8-Encoded MiR-29a Ameliorates Hepatic Fibrosis in Carbon Tetrachloride-Treated Mice.
    PLoS One. 2015;10:e0124411.
    PubMed     Text format     Abstract available


  103. ZHANG Q, Li Y, Han T, Nie C, et al
    Comparison of current diagnostic criteria for acute-on-chronic liver failure.
    PLoS One. 2015;10:e0122158.
    PubMed     Text format     Abstract available


  104. LIANG T, Alloosh M, Bell LN, Fullenkamp A, et al
    Liver injury and fibrosis induced by dietary challenge in the Ossabaw miniature Swine.
    PLoS One. 2015;10:e0124173.
    PubMed     Text format     Abstract available


  105. KONUMA K, Itoh M, Suganami T, Kanai S, et al
    Eicosapentaenoic Acid ameliorates non-alcoholic steatohepatitis in a novel mouse model using melanocortin 4 receptor-deficient mice.
    PLoS One. 2015;10:e0121528.
    PubMed     Text format     Abstract available


  106. AMORAS EDA S, Gomes ST, Freitas FB, Santana BB, et al
    NGF and P75NTR gene expression is associated with the hepatic fibrosis stage due to viral and non-viral causes.
    PLoS One. 2015;10:e0121754.
    PubMed     Text format     Abstract available


  107. SCOTT C, Cha K, Rao R, Liddle C, et al
    Hepatocyte-specific deletion of ARNT (aryl hydrocarbon Receptor Nuclear Translocator) results in altered fibrotic gene expression in the thioacetamide model of liver injury.
    PLoS One. 2015;10:e0121650.
    PubMed     Text format     Abstract available


  108. TACHTATZIS PM, Marshall A, Aravinthan A, Verma S, et al
    Chronic Hepatitis B Virus Infection: The Relation between Hepatitis B Antigen Expression, Telomere Length, Senescence, Inflammation and Fibrosis.
    PLoS One. 2015;10:e0127511.
    PubMed     Text format     Abstract available


  109. MULLHAUPT B, Bruggmann P, Bihl F, Blach S, et al
    Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland.
    PLoS One. 2015;10:e0125214.
    PubMed     Text format     Abstract available


  110. LIU H, Fu J, Hong R, Liu L, et al
    Acoustic Radiation Force Impulse Elastography for the Non-Invasive Evaluation of Hepatic Fibrosis in Non-Alcoholic Fatty Liver Disease Patients: A Systematic Review & Meta-Analysis.
    PLoS One. 2015;10:e0127782.
    PubMed     Text format     Abstract available


  111. DOMAGALSKI K, Pawlowska M, Kozielewicz D, Dybowska D, et al
    The Impact of IL28B Genotype and Liver Fibrosis on the Hepatic Expression of IP10, IFI27, ISG15, and MX1 and Their Association with Treatment Outcomes in Patients with Chronic Hepatitis C.
    PLoS One. 2015;10:e0130899.
    PubMed     Text format     Abstract available


  112. ROLLET-KURHAJEC KC, Moodie EE, Walmsley S, Cooper C, et al
    Hepatic Fibrosis Progression in HIV-Hepatitis C Virus Co-Infection - The Effect of Sex on Risk of Significant Fibrosis Measured by Aspartate-to-Platelet Ratio Index.
    PLoS One. 2015;10:e0129868.
    PubMed     Text format     Abstract available


  113. YE L, Yu H, Li C, Hirsch ML, et al
    Adeno-Associated Virus Vector Mediated Delivery of the HBV Genome Induces Chronic Hepatitis B Virus Infection and Liver Fibrosis in Mice.
    PLoS One. 2015;10:e0130052.
    PubMed     Text format     Abstract available


  114. KASUMOV T, Li L, Li M, Gulshan K, et al
    Ceramide as a mediator of non-alcoholic Fatty liver disease and associated atherosclerosis.
    PLoS One. 2015;10:e0126910.
    PubMed     Text format     Abstract available


  115. BRAUN DL, Rauch A, Aouri M, Durisch N, et al
    A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients.
    PLoS One. 2015;10:e0133028.
    PubMed     Text format     Abstract available


  116. TACHI Y, Hirai T, Toyoda H, Tada T, et al
    Predictive Ability of Laboratory Indices for Liver Fibrosis in Patients with Chronic Hepatitis C after the Eradication of Hepatitis C Virus.
    PLoS One. 2015;10:e0133515.
    PubMed     Text format     Abstract available


  117. TSAI CF, Chu CJ, Huang YH, Wang YP, et al
    Detecting minimal hepatic encephalopathy in an endemic country for hepatitis B: the role of psychometrics and serum IL-6.
    PLoS One. 2015;10:e0128437.
    PubMed     Text format     Abstract available


  118. BANSAL R, Frelin L, Brenndorfer ED, Storm G, et al
    Hepatitis C Virus Nonstructural 3/4A Protein Dampens Inflammation and Contributes to Slow Fibrosis Progression during Chronic Fibrosis In Vivo.
    PLoS One. 2015;10:e0128466.
    PubMed     Text format     Abstract available


  119. MARQUEZ M, Romero-Cores P, Montes-Oca M, Martin-Aspas A, et al
    Immune Activation Response in Chronic HIV-Infected Patients: Influence of Hepatitis C Virus Coinfection.
    PLoS One. 2015;10:e0119568.
    PubMed     Text format     Abstract available


  120. LONG X, Chen Q, Zhao J, Rafaels N, et al
    An IL-13 Promoter Polymorphism Associated with Liver Fibrosis in Patients with Schistosoma japonicum.
    PLoS One. 2015;10:e0135360.
    PubMed     Text format     Abstract available


  121. AOUDJEHANE L, Bisch G, Scatton O, Granier C, et al
    Infection of Human Liver Myofibroblasts by Hepatitis C Virus: A Direct Mechanism of Liver Fibrosis in Hepatitis C.
    PLoS One. 2015;10:e0134141.
    PubMed     Text format     Abstract available


  122. TAMAKI N, Kurosaki M, Higuchi M, Takada H, et al
    Genetic Polymorphisms of IL28B and PNPLA3 Are Predictive for HCV Related Rapid Fibrosis Progression and Identify Patients Who Require Urgent Antiviral Treatment with New Regimens.
    PLoS One. 2015;10:e0137351.
    PubMed     Text format     Abstract available


  123. THANAPIROM K, Suksawatamnuay S, Sukeepaisarnjaroen W, Tangkijvanich P, et al
    Association between CXCL10 and DPP4 Gene Polymorphisms and a Complementary Role for Unfavorable IL28B Genotype in Prediction of Treatment Response in Thai Patients with Chronic Hepatitis C Virus Infection.
    PLoS One. 2015;10:e0137365.
    PubMed     Text format     Abstract available


  124. NIELSEN MJ, Kazankov K, Leeming DJ, Karsdal MA, et al
    Markers of Collagen Remodeling Detect Clinically Significant Fibrosis in Chronic Hepatitis C Patients.
    PLoS One. 2015;10:e0137302.
    PubMed     Text format     Abstract available


  125. LIM EJ, Chin R, Nachbur U, Silke J, et al
    Effect of Immunosuppressive Agents on Hepatocyte Apoptosis Post-Liver Transplantation.
    PLoS One. 2015;10:e0138522.
    PubMed     Text format     Abstract available


  126. ZHENG S, Lu Q, Xu Y, Wang X, et al
    GdCl3 Attenuates Schistosomiasis japonicum Egg-Induced Granulomatosis Accompanied by Decreased Macrophage Infiltration in Murine Liver.
    PLoS One. 2015;10:e0132222.
    PubMed     Text format     Abstract available


  127. WU WP, Chou CT, Chen RC, Lee CW, et al
    Non-Invasive Evaluation of Hepatic Fibrosis: The Diagnostic Performance of Magnetic Resonance Elastography in Patients with Viral Hepatitis B or C.
    PLoS One. 2015;10:e0140068.
    PubMed     Text format     Abstract available


  128. CHEN SH, Peng CY, Lai HC, Chang IP, et al
    Head-to-Head Comparison between Collagen Proportionate Area and Acoustic Radiation Force Impulse Elastography in Liver Fibrosis Quantification in Chronic Hepatitis C.
    PLoS One. 2015;10:e0140554.
    PubMed     Text format     Abstract available


  129. SCHMID P, Bregenzer A, Huber M, Rauch A, et al
    Progression of Liver Fibrosis in HIV/HCV Co-Infection: A Comparison between Non-Invasive Assessment Methods and Liver Biopsy.
    PLoS One. 2015;10:e0138838.
    PubMed     Text format     Abstract available


  130. MOTAWI TK, Shaker OG, El-Maraghy SA, Senousy MA, et al
    Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients.
    PLoS One. 2015;10:e0137706.
    PubMed     Text format     Abstract available


  131. MUSSINI C, Lorenzini P, Puoti M, Lichtner M, et al
    Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus.
    PLoS One. 2015;10:e0140877.
    PubMed     Text format     Abstract available


  132. KUMAGAI K, Tabu K, Sasaki F, Takami Y, et al
    Glycoprotein Nonmetastatic Melanoma B (Gpnmb)-Positive Macrophages Contribute to the Balance between Fibrosis and Fibrolysis during the Repair of Acute Liver Injury in Mice.
    PLoS One. 2015;10:e0143413.
    PubMed     Text format     Abstract available


  133. ZHANG X, Zhai L, Rong C, Qin X, et al
    Association of Ghrelin Gene Polymorphisms and Serum Ghrelin Levels with the Risk of Hepatitis B Virus-Related Liver Diseases in a Chinese Population.
    PLoS One. 2015;10:e0143069.
    PubMed     Text format     Abstract available


  134. AHN JM, Sinn DH, Gwak GY, Paik YH, et al
    Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients with Elevated Hepatitis B Virus DNA Levels.
    PLoS One. 2015;10:e0144777.
    PubMed     Text format     Abstract available


  135. PETTA S, Marrone O, Torres D, Buttacavoli M, et al
    Obstructive Sleep Apnea Is Associated with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease.
    PLoS One. 2015;10:e0142210.
    PubMed     Text format     Abstract available


  136. SCHEINER B, Mandorfer M, Schwabl P, Payer BA, et al
    The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection.
    PLoS One. 2015;10:e0143429.
    PubMed     Text format     Abstract available


  137. BERNSMEIER C, Weisskopf DM, Pflueger MO, Mosimann J, et al
    Sleep Disruption and Daytime Sleepiness Correlating with Disease Severity and Insulin Resistance in Non-Alcoholic Fatty Liver Disease: A Comparison with Healthy Controls.
    PLoS One. 2015;10:e0143293.
    PubMed     Text format     Abstract available


  138. WADE AJ, Macdonald DM, Doyle JS, Gordon A, et al
    The Cascade of Care for an Australian Community-Based Hepatitis C Treatment Service.
    PLoS One. 2015;10:e0142770.
    PubMed     Text format     Abstract available


  139. CHENG J, Hou J, Ding H, Chen G, et al
    Validation of Ten Noninvasive Diagnostic Models for Prediction of Liver Fibrosis in Patients with Chronic Hepatitis B.
    PLoS One. 2015;10:e0144425.
    PubMed     Text format     Abstract available


    January 2014
  140. AL-QAHTANI AA, Al-Anazi MR, Abdo AA, Sanai FM, et al
    Association between HLA Variations and Chronic Hepatitis B Virus Infection in Saudi Arabian Patients.
    PLoS One. 2014;9:e80445.
    PubMed     Text format     Abstract available


  141. MANDORFER M, Bota S, Schwabl P, Bucsics T, et al
    Proton Pump Inhibitor Intake neither Predisposes to Spontaneous Bacterial Peritonitis or Other Infections nor Increases Mortality in Patients with Cirrhosis and Ascites.
    PLoS One. 2014;9:e110503.
    PubMed     Text format     Abstract available


  142. CHURIN Y, Roderfeld M, Stiefel J, Wurger T, et al
    Pathological impact of hepatitis B virus surface proteins on the liver is associated with the host genetic background.
    PLoS One. 2014;9:e90608.
    PubMed     Text format     Abstract available


  143. HALL RA, Liebe R, Hochrath K, Kazakov A, et al
    Systems genetics of liver fibrosis: identification of fibrogenic and expression quantitative trait loci in the BXD murine reference population.
    PLoS One. 2014;9:e89279.
    PubMed     Text format     Abstract available


  144. MAASOUMY B, Hunyady B, Calvaruso V, Makara M, et al
    Performance of Two HCV RNA Assays during Protease Inhibitor-Based Triple Therapy in Patients with Advanced Liver Fibrosis and Cirrhosis.
    PLoS One. 2014;9:e110857.
    PubMed     Text format     Abstract available


  145. SAVERINO D, Pesce G, Antola P, Porcelli B, et al
    High levels of soluble ctla-4 are present in anti-mitochondrial antibody positive, but not in antibody negative patients with primary biliary cirrhosis.
    PLoS One. 2014;9:e112509.
    PubMed     Text format     Abstract available


  146. KALLIS YN, Scotton CJ, Mackinnon AC, Goldin RD, et al
    Proteinase activated receptor 1 mediated fibrosis in a mouse model of liver injury: a role for bone marrow derived macrophages.
    PLoS One. 2014;9:e86241.
    PubMed     Text format     Abstract available



  147. Correction: Impaired Expression of Type I and Type II Interferon Receptors in HCV-Associated Chronic Liver Disease and Liver Cirrhosis.
    PLoS One. 2014;9:e114456.
    PubMed     Text format     Abstract available


  148. WANNHOFF A, Muller OJ, Friedrich K, Rupp C, et al
    Effects of increased von Willebrand factor levels on primary hemostasis in thrombocytopenic patients with liver cirrhosis.
    PLoS One. 2014;9:e112583.
    PubMed     Text format     Abstract available


  149. KING LY, Johnson KB, Zheng H, Wei L, et al
    Host Genetics Predict Clinical Deterioration in HCV-Related Cirrhosis.
    PLoS One. 2014;9:e114747.
    PubMed     Text format     Abstract available


  150. PETTA S, Miele L, Bugianesi E, Camma C, et al
    Glucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic Fatty liver disease.
    PLoS One. 2014;9:e87523.
    PubMed     Text format     Abstract available


  151. KOJIMA K, April C, Canasto-Chibuque C, Chen X, et al
    Transcriptome profiling of archived sectioned formalin-fixed paraffin-embedded (AS-FFPE) tissue for disease classification.
    PLoS One. 2014;9:e86961.
    PubMed     Text format     Abstract available


  152. DIJKSTRA H, Handayani A, Kappert P, Oudkerk M, et al
    Clinical implications of non-steatotic hepatic fat fractions on quantitative diffusion-weighted imaging of the liver.
    PLoS One. 2014;9:e87926.
    PubMed     Text format     Abstract available


  153. XIE Q, Zhou X, Huang P, Wei J, et al
    The performance of enhanced liver fibrosis (ELF) test for the staging of liver fibrosis: a meta-analysis.
    PLoS One. 2014;9:e92772.
    PubMed     Text format     Abstract available


  154. ISHIZU-HIGASHI S, Seno H, Nishi E, Matsumoto Y, et al
    Deletion of nardilysin prevents the development of steatohepatitis and liver fibrotic changes.
    PLoS One. 2014;9:e98017.
    PubMed     Text format     Abstract available


  155. FUGIER E, Marche H, Thelu MA, Macek Jilkova Z, et al
    Functions of liver natural killer cells are dependent on the severity of liver inflammation and fibrosis in chronic hepatitis C.
    PLoS One. 2014;9:e95614.
    PubMed     Text format     Abstract available


  156. PANG JX, Zimmer S, Niu S, Crotty P, et al
    Liver stiffness by transient elastography predicts liver-related complications and mortality in patients with chronic liver disease.
    PLoS One. 2014;9:e95776.
    PubMed     Text format     Abstract available


  157. WESTRA IM, Oosterhuis D, Groothuis GM, Olinga P, et al
    The effect of antifibrotic drugs in rat precision-cut fibrotic liver slices.
    PLoS One. 2014;9:e95462.
    PubMed     Text format     Abstract available


  158. RENGA B, Francisci D, Schiaroli E, Carino A, et al
    The HIV Matrix Protein p17 Promotes the Activation of Human Hepatic Stellate Cells through Interactions with CXCR2 and Syndecan-2.
    PLoS One. 2014;9:e94798.
    PubMed     Text format     Abstract available


  159. SATO M, Kondo M, Tateishi R, Fujiwara N, et al
    Impact of IL28B Genetic Variation on HCV-Induced Liver Fibrosis, Inflammation, and Steatosis: A Meta-Analysis.
    PLoS One. 2014;9:e91822.
    PubMed     Text format     Abstract available


  160. KARLAS T, Petroff D, Garnov N, Bohm S, et al
    Non-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopy.
    PLoS One. 2014;9:e91987.
    PubMed     Text format     Abstract available


  161. HUANG X, Wang X, Lv Y, Xu L, et al
    Protection effect of kallistatin on carbon tetrachloride-induced liver fibrosis in rats via antioxidative stress.
    PLoS One. 2014;9:e88498.
    PubMed     Text format     Abstract available


  162. TSAI TH, Shih SC, Ho TC, Ma HI, et al
    Pigment epithelium-derived factor 34-mer peptide prevents liver fibrosis and hepatic stellate cell activation through down-regulation of the PDGF receptor.
    PLoS One. 2014;9:e95443.
    PubMed     Text format     Abstract available


  163. BANSAL R, Prakash J, De Ruiter M, Poelstra K, et al
    Targeted recombinant fusion proteins of IFNgamma and mimetic IFNgamma with PDGFbetaR bicyclic peptide inhibits liver fibrogenesis in vivo.
    PLoS One. 2014;9:e89878.
    PubMed     Text format     Abstract available


  164. YAQOOB U, Jagavelu K, Shergill U, de Assuncao T, et al
    FGF21 promotes endothelial cell angiogenesis through a dynamin-2 and Rab5 dependent pathway.
    PLoS One. 2014;9:e98130.
    PubMed     Text format     Abstract available


  165. RASHID SK, Khodja NI, Auger C, Alhosin M, et al
    Probiotics (VSL#3) Prevent Endothelial Dysfunction in Rats with Portal Hypertension: Role of the Angiotensin System.
    PLoS One. 2014;9:e97458.
    PubMed     Text format     Abstract available


  166. HAYES BJ, Riehle KJ, Shimizu-Albergine M, Bauer RL, et al
    Activation of platelet-derived growth factor receptor alpha contributes to liver fibrosis.
    PLoS One. 2014;9:e92925.
    PubMed     Text format     Abstract available


  167. KALDENBACH M, Cubero FJ, Erschfeld S, Liedtke C, et al
    Hepatic tissue environment in NEMO-deficient mice critically regulates positive selection of donor cells after hepatocyte transplantation.
    PLoS One. 2014;9:e100786.
    PubMed     Text format     Abstract available


  168. CORCHADO S, Lopez-Cortes LF, Rivero-Juarez A, Torres-Cornejo A, et al
    Liver Fibrosis, Host Genetic and Hepatitis C Virus Related Parameters as Predictive Factors of Response to Therapy against Hepatitis C Virus in HIV/HCV Coinfected Patients.
    PLoS One. 2014;9:e101760.
    PubMed     Text format     Abstract available


  169. SONG Y, Zhan L, Yu M, Huang C, et al
    TRPV4 channel inhibits TGF-beta1-induced proliferation of hepatic stellate cells.
    PLoS One. 2014;9:e101179.
    PubMed     Text format     Abstract available


  170. ALKHOURI N, Mansoor S, Giammaria P, Liccardo D, et al
    The development of the pediatric NAFLD fibrosis score (PNFS) to predict the presence of advanced fibrosis in children with nonalcoholic fatty liver disease.
    PLoS One. 2014;9:e104558.
    PubMed     Text format     Abstract available


  171. KORHAN P, Erdal E, Kandemis E, Cokakli M, et al
    Reciprocal activating crosstalk between c-Met and caveolin 1 promotes invasive phenotype in hepatocellular carcinoma.
    PLoS One. 2014;9:e105278.
    PubMed     Text format     Abstract available


  172. ZHANG Y, Li Y, Lin C, Ding J, et al
    Aberrant upregulation of 14-3-3sigma and EZH2 expression serves as an inferior prognostic biomarker for hepatocellular carcinoma.
    PLoS One. 2014;9:e107251.
    PubMed     Text format     Abstract available


  173. THIELE M, Gluud LL, Fialla AD, Dahl EK, et al
    Large variations in risk of hepatocellular carcinoma and mortality in treatment naive hepatitis B patients: systematic review with meta-analyses.
    PLoS One. 2014;9:e107177.
    PubMed     Text format     Abstract available


  174. BERGLIN L, Bergquist A, Johansson H, Glaumann H, et al
    In situ characterization of intrahepatic non-parenchymal cells in PSC reveals phenotypic patterns associated with disease severity.
    PLoS One. 2014;9:e105375.
    PubMed     Text format     Abstract available


  175. KUO YH, Lu SN, Chen CH, Chang KC, et al
    The changes of liver stiffness and its associated factors for chronic hepatitis B patients with entecavir therapy.
    PLoS One. 2014;9:e93160.
    PubMed     Text format     Abstract available


  176. ZHANG Y, Mao R, Yan R, Cai D, et al
    Transcription of Hepatitis B Virus Covalently Closed Circular DNA Is Regulated by CpG Methylation during Chronic Infection.
    PLoS One. 2014;9:e110442.
    PubMed     Text format     Abstract available


  177. DE NICOLA S, Dongiovanni P, Aghemo A, Cheroni C, et al
    Interaction between PNPLA3 I148M Variant and Age at Infection in Determining Fibrosis Progression in Chronic Hepatitis C.
    PLoS One. 2014;9:e106022.
    PubMed     Text format     Abstract available


  178. MOSCA E, Alfieri R, Milanesi L
    Diffusion of Information throughout the Host Interactome Reveals Gene Expression Variations in Network Proximity to Target Proteins of Hepatitis C Virus.
    PLoS One. 2014;9:e113660.
    PubMed     Text format     Abstract available


  179. LUNDBO LF, Clausen LN, Weis N, Schonning K, et al
    Influence of Hepatitis C Virus and IL28B Genotypes on Liver Stiffness.
    PLoS One. 2014;9:e115882.
    PubMed     Text format     Abstract available


  180. LI Y, Chen Y, Zhao Y
    The Diagnostic Value of the FIB-4 Index for Staging Hepatitis B-Related Fibrosis: A Meta-Analysis.
    PLoS One. 2014;9:e105728.
    PubMed     Text format     Abstract available


  181. LIU M, Wu Q, Chen P, Buchele B, et al
    A Boswellic Acid-Containing Extract Ameliorates Schistosomiasis Liver Granuloma and Fibrosis through Regulating NF-kappaB Signaling in Mice.
    PLoS One. 2014;9:e100129.
    PubMed     Text format     Abstract available


  182. YEHIA BR, Schranz AJ, Umscheid CA, Lo Re V 3rd, et al
    The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis.
    PLoS One. 2014;9:e101554.
    PubMed     Text format     Abstract available


  183. KIM MS, Kim S, Myung H
    Degradation of AIMP1/p43 Induced by Hepatitis C Virus E2 Leads to Upregulation of TGF-beta Signaling and Increase in Surface Expression of gp96.
    PLoS One. 2014;9:e96302.
    PubMed     Text format     Abstract available


  184. TSENG CW, Chen CY, Chang TT, Tzeng SJ, et al
    Peginterferon alfa-2a is associated with elevations in alanine aminotransferase at the end of treatment in chronic hepatitis C patients with sustained virologic response.
    PLoS One. 2014;9:e100207.
    PubMed     Text format     Abstract available


  185. JANSEN C, Leeming DJ, Mandorfer M, Byrjalsen I, et al
    PRO-C3-Levels in Patients with HIV/HCV-Co-Infection Reflect Fibrosis Stage and Degree of Portal Hypertension.
    PLoS One. 2014;9:e108544.
    PubMed     Text format     Abstract available


  186. CHRISTIANSEN KM, Mossner BK, Hansen JF, Jarnbjer EF, et al
    Liver Stiffness Measurement among Patients with Chronic Hepatitis B and C: Results from a 5-Year Prospective Study.
    PLoS One. 2014;9:e111912.
    PubMed     Text format     Abstract available


  187. HONG MZ, Zhang RM, Chen GL, Huang WQ, et al
    Liver stiffness measurement-based scoring system for significant inflammation related to chronic hepatitis B.
    PLoS One. 2014;9:e111641.
    PubMed     Text format     Abstract available


  188. ZHU X, Zhang J, Fan W, Gong Y, et al
    MAPKAP1 rs10118570 Polymorphism Is Associated with Anti-Infection and Anti-Hepatic Fibrogenesis in Schistosomiasis Japonica.
    PLoS One. 2014;9:e105995.
    PubMed     Text format     Abstract available


  189. CHEN J, Xu X, Wu J, Ling Q, et al
    The stratifying value of hangzhou criteria in liver transplantation for hepatocellular carcinoma.
    PLoS One. 2014;9:e93128.
    PubMed     Text format     Abstract available


  190. DVORAK K, Stritesky J, Petrtyl J, Vitek L, et al
    Use of non-invasive parameters of non-alcoholic steatohepatitis and liver fibrosis in daily practice - an exploratory case-control study.
    PLoS One. 2014;9:e111551.
    PubMed     Text format     Abstract available


  191. COSGROVE C, Berger CT, Kroy DC, Cheney PC, et al
    Chronic HCV infection affects the NK cell phenotype in the blood more than in the liver.
    PLoS One. 2014;9:e105950.
    PubMed     Text format     Abstract available


    January 2013
  192. LIU Y, El-Serag HB, Jiao L, Lee J, et al
    WNT Signaling Pathway Gene Polymorphisms and Risk of Hepatic Fibrosis and Inflammation in HCV-Infected Patients.
    PLoS One. 2013;8:e84407.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Cirrhosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: